West Pharmaceutical Services - 股票

West Pharmaceutical Services 负债 2024

West Pharmaceutical Services 负债

-647.1 USD

股票代码

WST

ISIN

US9553061055

WKN

864330

在2024年,West Pharmaceutical Services的债务为-647.1 USD,与前一年-685.4 USD的总债务相比变动了-5.59%

West Pharmaceutical Services Aktienanalyse

West Pharmaceutical Services在做什么?

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

West Pharmaceutical Services的债务结构理解

West Pharmaceutical Services的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况,风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对West Pharmaceutical Services多年债务结构的分析,可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率,而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注West Pharmaceutical Services的债务,因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力,而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

West Pharmaceutical Services债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力,而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于West Pharmaceutical Services股票的常见问题

West Pharmaceutical Services今年的债务有多高?

West Pharmaceutical Services今年的债务水平为-647.1 USD。

West Pharmaceutical Services的债务与去年相比有多高?

West Pharmaceutical Services的债务与去年相比增长了-5.59% 下降了

West Pharmaceutical Services的投资者高额债务会有什么后果?

对于West Pharmaceutical Services的投资者来说,高额债务可能构成风险,因为它会使公司的财务状况变得较弱,可能会影响其履行义务的能力。

West Pharmaceutical Services的投资者低债务会有什么后果?

低债务意味着West Pharmaceutical Services拥有强大的财务地位,并且能够履行其义务,而不会导致其财务负担过重。

West Pharmaceutical Services的债务增加对公司会有什么影响?

West Pharmaceutical Services的债务增加可能会影响公司的财务状况,从而导致其财务负担增加。

West Pharmaceutical Services的债务减少会对公司产生什么影响?

将West Pharmaceutical Services的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

West Pharmaceutical Services的债务受哪些因素影响?

影响West Pharmaceutical Services负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么West Pharmaceutical Services的债务对投资者如此重要?

West Pharmaceutical Services的债务对投资者来说很重要,因为它是公司财务稳定性的指标,并且能向投资者提供有关公司如何履行其财务义务的信息。

West Pharmaceutical Services可以采取哪些战略措施来改变债务状况?

为了改变债务状况,West Pharmaceutical Services可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查,以确定最佳的战略措施来改变其债务状况。

West Pharmaceutical Services支付多少股息?

在过去的12个月中,West Pharmaceutical Services支付了0.77 USD 的股息。这相当于大约0.23 %的股息收益率。在未来的12个月内,West Pharmaceutical Services预计将支付0.92 USD的股息。

West Pharmaceutical Services的股息收益率有多高?

West Pharmaceutical Services当前的股息收益率为0.23 %。

West Pharmaceutical Services什么时候支付股息?

West Pharmaceutical Services按季度支付股息。这些股息将在, , , 月份分发。

West Pharmaceutical Services的股息有多安全?

West Pharmaceutical Services 在过去53年里每年都支付了股息。

West Pharmaceutical Services的股息有多高?

预计未来12个月的股息将达到0.92 USD。这相当于0.27 %的股息收益率。

West Pharmaceutical Services位于哪个行业?

West Pharmaceutical Services 被分配到“健康”板块。

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

要获得West Pharmaceutical Services在支付的0.2 USD的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

West Pharmaceutical Services最后一次支付股息是什么时候?

上一次股息发放日期为。

West Pharmaceutical Services在2023年的股息是多少?

在2023年,West Pharmaceutical Services 分配了0.73 USD作为股息。

West Pharmaceutical Services 的股息是以哪种货币支付的?

West Pharmaceutical Services的股息将以USD的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

West Pharmaceutical Services 股票在以下供应商处可进行定投计划:Trade Republic

Andere Kennzahlen von West Pharmaceutical Services

我们对West Pharmaceutical Services 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和West Pharmaceutical Services 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: